Discontinuation report ODAN-INDOMETHACIN
Report ID | 189777 |
Drug Identification Number | 02231799 |
Brand name | SANDOZ INDOMETHACIN |
Common or Proper name | INDOMETHACIN |
Company Name | ODAN LABORATORIES LTD |
Market Status | MARKETED |
Active Ingredient(s) | INDOMETHACIN |
Strength(s) | 50MG |
Dosage form(s) | SUPPOSITORY |
Route of administration | RECTAL RECTAL |
Packaging size | 30SUP |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2023-04-18 |
Remaining supply date | 2023-04-18 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Sandoz divestment of the following product to Odan in Canada |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2023-04-19 | English | Compare |
v2 | 2023-04-18 | French | Compare |
v1 | 2023-04-18 | English | Compare |
Showing 1 to 3 of 3